Observational studyMedicine2025
A retrospective study on the predictive efficacy of SOBDA and VSRQ scales for prognosis in elderly COPD patients.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This retrospective study aimed to compare the predictive efficacy of the shortness of breath with daily activities (SOBDA) and ventilatory response to exercise questionnaire (VSRQ) in forecasting respiratory-related adverse events in elderly patients with chronic obstructive pulmonary disease (COPD) over a 6-month follow-up period post-discharge. A total of 92 COPD patients, treated according to the 2022 GOLD report and Chinese National COPD treatment guidelines, were enrolled. SOBDA and VSRQ scores were collected upon admission and assessed daily for the first 7 days. A random forest model was used to evaluate the predictive value of these scores in relation to respiratory adverse events, with a training/testing group split at a 4:1 ratio. Five patients were excluded due to loss to follow-up or death, resulting in 87 patients in the final analysis. The primary endpoint was the occurrence of COPD exacerbations and respiratory failure. The random forest model using VSRQ scores as the response variable outperformed the SOBDA model in terms of predictive accuracy (AUC: 0.84 vs 0.65) and error rate (21.74% vs 22%). Both models demonstrated high accuracy in predicting the absence of adverse events (VSRQ: 85.72%, SOBDA: 83.67%) but showed limited sensitivity in predicting their occurrence (VSRQ: 35%, SOBDA: 40%). The VSRQ questionnaire demonstrated superior predictive performance compared to SOBDA, suggesting that VSRQ may be a useful tool for identifying high-risk elderly COPD patients and guiding clinical decision-making. Further studies are needed to confirm these findings and explore the broader applicability of VSRQ in COPD prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.